Øjenafdelingen, Vejle Sygehus
Vejle, Denmark
NCT Number: NCT06647472
The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future.
The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control.
Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.
This study is active but is not currently recruiting participants.
Notify Me5 year–14 year
All sexes
Observational
Vejle, Denmark
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At baseline
Vejle Hospital
Other
Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control. The ProMOC Study
Acronym: ProMOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03919396
Eye Diseases, Myopia
Hong Kong
View Trial DetailsNCT05635526
Eye Diseases, Myopia
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT05365373
Eye Diseases, Myopia
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT05348369
Eye Diseases, Myopia
Tianjin, Tianjin Municipality, China
View Trial Details